| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $309.3M | $313.0M | $296.6M |
| YoY Revenue Growth % | -1.2% | +5.5% | — |
| Gross Profit | $232.0M | $241.4M | — |
| Gross Margin % | 75.0% | 77.1% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$254.7M | -$7.8M | -$111.4M |
| Operating Margin % | -80.0% | -2.5% | -37.6% |
| Net Income (GAAP) | -$256.7M | -$10.2M | -$110.5M |
| EBITDA (Normalized) | -$254.5M | -$7.0M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $91.1M | $150.1M | $103.6M |
| Capital Expenditures (CapEx) | $286.0K | $989.0K | — |
| Free Cash Flow (FCF) | $90.8M | $149.1M | $103.6M |
| FCF Margin % | 29.4% | 47.6% | 34.9% |
| Return on Invested Capital (ROIC %) | -31.0% | -0.6% | — |
| Cash & Short-Term Equivalents | $115.7M | $189.5M | — |
| Total Debt (Short + Long Term) | $280.1M | $496.8M | — |
| Total Stockholders' Equity | $484.4M | $761.3M | — |